Skip to main content
. 2020 Oct;12(10):5857–5868. doi: 10.21037/jtd-20-1678

Table 3. Baseline characteristics of patients with NIV intolerance prior to treatment.

Variables Overall (n=90) REM (n=52) DEX (n=38) P value
Reasons of NIV 0.641
   Cardiogenic, n (%) 82 (91.1) 48 (92.3) 34 (89.5)
   Non-cardiogenic, n (%) 8 (9.9) 4 (7.7) 4 (10.5)
Duration from surgery to extubation, h 37 (18, 67) 34 (17, 75) 39 (19, 64) 0.759
Duration from extubation to NIV, h 24 (5, 41) 23 (2, 39) 25 (6, 49) 0.794
Duration from NIV to sedation, min 12 (8, 114) 11 (9, 99) 12 (7, 133) 0.697
NIV parameters
   Support pressure, cm H2O 10(10, 12) 10(10, 12) 11(10, 12) 0.871
   FiO2, % 60(50, 70) 60(50, 70) 60(50, 70) 0.359
   Tidal volume, ml/kg, PBW 8(7, 10) 8(7, 10) 8(7, 11) 0.452
NIS 0.661
   4 score, n (%) 34 (37.8) 21 (40.4) 13 (34.2)
   3 score, n (%) 56 (62.2) 31 (59.6) 25 (65.8)
CPOT score 0.303
   0 score, n (%) 58 (64.4) 36 (69.2) 22 (57.9)
   1 score, n (%) 15 (16.7) 6 (11.6) 9 (23.7)
   2 score, n (%) 17 (18.9) 10 (19.2) 7 (18.4)
Vital signs
   HR, beats/min 102±18 104±20 99±15 0.192
   RR, breaths/min 27±8 28±8 25±8 0.157
   SBP, mmHg 142±27 143±29 140±23 0.548
   DBP, mmHg 65±15 65±17 66±14 0.746
   MAP, mmHg 91±17 91±19 91±14 0.879
   SpO2, % 98 (94, 100) 98 (95, 99) 97 (93, 100) 0.368
   PH 7.45±0.06 7.44±0.07 7.45±0.04 0.296
   PaO2, mmHg 95.47±39.85 100.24±44.64 87.98±30.40 0.27
   PaCO2, mmHg 39.51±7.67 40.30±8.93 38.25±5.05 0.345
   LVEF, % 60 (51, 64) 59 (53, 64) 60 (45, 64) 0.685
   NT-pro BNP, pg/mL 2,225 (1,130, 5,564) 2,675 (1,366, 4,357) 1,964 (814, 8,492) 0.482

Continuous data are presented as the mean (SD) or median (IQR). Categorical data are presented as counts (%). NIV, noninvasive ventilation; PBW, predicted body weight; NIS, NIV intolerance score; CPOT, Critical-Care Pain Observation Tool; HR, heart rate; RR, respiratory rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean artery pressure, LVEF, left ventricular ejection fraction; NT-pro BNT, N terminal pro B type natriuretic peptide.